Long‐term clinical outcomes in steatotic liver disease and incidence of liver‐related events, cardiovascular events and all‐cause mortality
N Tamaki, T Kimura, SI Wakabayashi… - Alimentary …, 2024 - Wiley Online Library
Background A multi‐society consensus group proposed a new nomenclature for steatotic
liver disease (SLD) including metabolic‐dysfunction associated steatotic liver disease …
liver disease (SLD) including metabolic‐dysfunction associated steatotic liver disease …
Multi-organ linkage pathophysiology and therapy for NAFLD and NASH
T Kimura, T Yamazaki, GR Estrela - Frontiers in Endocrinology, 2024 - frontiersin.org
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), now
referred to as metabolic dysfunction-associated steatotic liver disease (MASLD) and …
referred to as metabolic dysfunction-associated steatotic liver disease (MASLD) and …
[引用][C] Has MetALD met the presumption? Authors' reply
N Tamaki, T Kimura, SI Wakabayashi… - Alimentary …, 2024 - Wiley Online Library
Editorial: Has MetALD met the presumption? Authors' reply Page 1 Aliment Pharmacol Ther.
2024;00:1–2. wileyonlinelibrary.com/journal/apt | 1 © 2024 John Wiley & Sons Ltd. DOI …
2024;00:1–2. wileyonlinelibrary.com/journal/apt | 1 © 2024 John Wiley & Sons Ltd. DOI …